Novartis’ Entresto faces first US generic competitorsnews2025-08-05T17:59:12+00:00August 5th, 2025|Endpoints News|
Pfizer CEO says drugmakers are ready to work with Trump on direct sales programnews2025-08-05T15:20:05+00:00August 5th, 2025|Endpoints News|
Madrigal’s MASH drug handily tops forecasts as execs discuss GLP-1 combosnews2025-08-05T15:07:44+00:00August 5th, 2025|Endpoints News|
Trump warns pharma tariffs are coming ‘in the next week or so’ news2025-08-05T14:55:34+00:00August 5th, 2025|Endpoints News|
Pfizer says some tariffs and MFN impact factored in guidancenews2025-08-05T11:33:21+00:00August 5th, 2025|Endpoints News|
Amgen, Lilly can continue fight over alleged improper drug discounts, judge rulesnews2025-08-05T10:31:13+00:00August 5th, 2025|Endpoints News|
Vertex’s top scientist Altshuler to retire, next-generation pain drug failsnews2025-08-05T00:57:40+00:00August 5th, 2025|Endpoints News|
J&J divests from some of its incubator sitesnews2025-08-04T19:47:20+00:00August 4th, 2025|Endpoints News|
BioNTech sales grow, braces for FDA decision on updated Covid vaccinenews2025-08-04T11:05:41+00:00August 4th, 2025|Endpoints News|
CMS considers pilot plan for covering weight loss drugs — reportnews2025-08-01T19:02:02+00:00August 1st, 2025|Endpoints News|
